IBDEI0QH ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,11912,1,2,0)
 ;;=2^J3380
 ;;^UTILITY(U,$J,358.3,11912,1,3,0)
 ;;=3^VEDOLIZUMAB/ENTYVIO 1MG
 ;;^UTILITY(U,$J,358.3,11913,0)
 ;;=J7609^^48^580^5^^^^1
 ;;^UTILITY(U,$J,358.3,11913,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11913,1,2,0)
 ;;=2^J7609
 ;;^UTILITY(U,$J,358.3,11913,1,3,0)
 ;;=3^ALBUTEROL,COMPOUND,UNIT DOSE,1MG
 ;;^UTILITY(U,$J,358.3,11914,0)
 ;;=J7610^^48^580^4^^^^1
 ;;^UTILITY(U,$J,358.3,11914,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11914,1,2,0)
 ;;=2^J7610
 ;;^UTILITY(U,$J,358.3,11914,1,3,0)
 ;;=3^ALBUTEROL,COMPOUND,CONCENTRATE,1MG
 ;;^UTILITY(U,$J,358.3,11915,0)
 ;;=J0735^^48^580^27^^^^1
 ;;^UTILITY(U,$J,358.3,11915,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11915,1,2,0)
 ;;=2^J0735
 ;;^UTILITY(U,$J,358.3,11915,1,3,0)
 ;;=3^CLONIDINE HYDROCHLORIDE 1MG
 ;;^UTILITY(U,$J,358.3,11916,0)
 ;;=J1438^^48^580^35^^^^1
 ;;^UTILITY(U,$J,358.3,11916,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11916,1,2,0)
 ;;=2^J1438
 ;;^UTILITY(U,$J,358.3,11916,1,3,0)
 ;;=3^ETANERCEPT 25MG
 ;;^UTILITY(U,$J,358.3,11917,0)
 ;;=J7611^^48^580^6^^^^1
 ;;^UTILITY(U,$J,358.3,11917,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11917,1,2,0)
 ;;=2^J7611
 ;;^UTILITY(U,$J,358.3,11917,1,3,0)
 ;;=3^ALBUTEROL,NON-COMPOUND,CONCENTRATE,1MG
 ;;^UTILITY(U,$J,358.3,11918,0)
 ;;=J7613^^48^580^7^^^^1
 ;;^UTILITY(U,$J,358.3,11918,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11918,1,2,0)
 ;;=2^J7613
 ;;^UTILITY(U,$J,358.3,11918,1,3,0)
 ;;=3^ALBUTEROL,NON-COMPOUND,UNIT DOSE,1MG
 ;;^UTILITY(U,$J,358.3,11919,0)
 ;;=J2680^^48^580^41^^^^1
 ;;^UTILITY(U,$J,358.3,11919,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11919,1,2,0)
 ;;=2^J2680
 ;;^UTILITY(U,$J,358.3,11919,1,3,0)
 ;;=3^FLUPHENAZINE DECANOATE,UP TO 25MG
 ;;^UTILITY(U,$J,358.3,11920,0)
 ;;=J1580^^48^580^47^^^^1
 ;;^UTILITY(U,$J,358.3,11920,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11920,1,2,0)
 ;;=2^J1580
 ;;^UTILITY(U,$J,358.3,11920,1,3,0)
 ;;=3^GARAMYCIN,GENTAMICIN,UP TO 80MG
 ;;^UTILITY(U,$J,358.3,11921,0)
 ;;=J2350^^48^580^80^^^^1
 ;;^UTILITY(U,$J,358.3,11921,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11921,1,2,0)
 ;;=2^J2350
 ;;^UTILITY(U,$J,358.3,11921,1,3,0)
 ;;=3^OCRELIZUMAB 1MG
 ;;^UTILITY(U,$J,358.3,11922,0)
 ;;=J3590^^48^580^105^^^^1
 ;;^UTILITY(U,$J,358.3,11922,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11922,1,2,0)
 ;;=2^J3590
 ;;^UTILITY(U,$J,358.3,11922,1,3,0)
 ;;=3^UNCLASSIFIED BIOLOGICS
 ;;^UTILITY(U,$J,358.3,11923,0)
 ;;=J3490^^48^580^106^^^^1
 ;;^UTILITY(U,$J,358.3,11923,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11923,1,2,0)
 ;;=2^J3490
 ;;^UTILITY(U,$J,358.3,11923,1,3,0)
 ;;=3^UNCLASSIFIED DRUG
 ;;^UTILITY(U,$J,358.3,11924,0)
 ;;=J0135^^48^580^3^^^^1
 ;;^UTILITY(U,$J,358.3,11924,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11924,1,2,0)
 ;;=2^J0135
 ;;^UTILITY(U,$J,358.3,11924,1,3,0)
 ;;=3^ADALIMUMAB 20MG
 ;;^UTILITY(U,$J,358.3,11925,0)
 ;;=J1569^^48^580^45^^^^1
 ;;^UTILITY(U,$J,358.3,11925,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11925,1,2,0)
 ;;=2^J1569
 ;;^UTILITY(U,$J,358.3,11925,1,3,0)
 ;;=3^GAMMAGARD LIQUID 500MG
 ;;^UTILITY(U,$J,358.3,11926,0)
 ;;=J1566^^48^580^51^^^^1
 ;;^UTILITY(U,$J,358.3,11926,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11926,1,2,0)
 ;;=2^J1566
 ;;^UTILITY(U,$J,358.3,11926,1,3,0)
 ;;=3^IMMUNE GLOBULIN 500MG
 ;;^UTILITY(U,$J,358.3,11927,0)
 ;;=J2182^^48^580^69^^^^1
 ;;^UTILITY(U,$J,358.3,11927,1,0)
 ;;=^358.31IA^3^2
 
--- Routine Detail   --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0QH   3769     printed  Sep 23, 2025@19:29:46                                                                                                                                                                                                    Page 2
IBDEI0QH  ; ; 01-FEB-2022
 +1       ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 +2        if 'DIFQR(358.3)
               QUIT 
           FOR I=1:2
               SET X=$TEXT(Q+I)
               if X=""
                   QUIT 
               SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
               SET X=$EXTRACT(X,4,999)
               if $ASCII(Y)=126
                   SET I=I+1
                   SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
               if $ASCII(Y)=61
                   SET Y=$EXTRACT(Y,2,999)
               XECUTE NO
              IF '$TEST
                   SET @X=Y
Q          QUIT 
 +1       ;;^UTILITY(U,$J,358.3,11912,1,2,0)
 +2       ;;=2^J3380
 +3       ;;^UTILITY(U,$J,358.3,11912,1,3,0)
 +4       ;;=3^VEDOLIZUMAB/ENTYVIO 1MG
 +5       ;;^UTILITY(U,$J,358.3,11913,0)
 +6       ;;=J7609^^48^580^5^^^^1
 +7       ;;^UTILITY(U,$J,358.3,11913,1,0)
 +8       ;;=^358.31IA^3^2
 +9       ;;^UTILITY(U,$J,358.3,11913,1,2,0)
 +10      ;;=2^J7609
 +11      ;;^UTILITY(U,$J,358.3,11913,1,3,0)
 +12      ;;=3^ALBUTEROL,COMPOUND,UNIT DOSE,1MG
 +13      ;;^UTILITY(U,$J,358.3,11914,0)
 +14      ;;=J7610^^48^580^4^^^^1
 +15      ;;^UTILITY(U,$J,358.3,11914,1,0)
 +16      ;;=^358.31IA^3^2
 +17      ;;^UTILITY(U,$J,358.3,11914,1,2,0)
 +18      ;;=2^J7610
 +19      ;;^UTILITY(U,$J,358.3,11914,1,3,0)
 +20      ;;=3^ALBUTEROL,COMPOUND,CONCENTRATE,1MG
 +21      ;;^UTILITY(U,$J,358.3,11915,0)
 +22      ;;=J0735^^48^580^27^^^^1
 +23      ;;^UTILITY(U,$J,358.3,11915,1,0)
 +24      ;;=^358.31IA^3^2
 +25      ;;^UTILITY(U,$J,358.3,11915,1,2,0)
 +26      ;;=2^J0735
 +27      ;;^UTILITY(U,$J,358.3,11915,1,3,0)
 +28      ;;=3^CLONIDINE HYDROCHLORIDE 1MG
 +29      ;;^UTILITY(U,$J,358.3,11916,0)
 +30      ;;=J1438^^48^580^35^^^^1
 +31      ;;^UTILITY(U,$J,358.3,11916,1,0)
 +32      ;;=^358.31IA^3^2
 +33      ;;^UTILITY(U,$J,358.3,11916,1,2,0)
 +34      ;;=2^J1438
 +35      ;;^UTILITY(U,$J,358.3,11916,1,3,0)
 +36      ;;=3^ETANERCEPT 25MG
 +37      ;;^UTILITY(U,$J,358.3,11917,0)
 +38      ;;=J7611^^48^580^6^^^^1
 +39      ;;^UTILITY(U,$J,358.3,11917,1,0)
 +40      ;;=^358.31IA^3^2
 +41      ;;^UTILITY(U,$J,358.3,11917,1,2,0)
 +42      ;;=2^J7611
 +43      ;;^UTILITY(U,$J,358.3,11917,1,3,0)
 +44      ;;=3^ALBUTEROL,NON-COMPOUND,CONCENTRATE,1MG
 +45      ;;^UTILITY(U,$J,358.3,11918,0)
 +46      ;;=J7613^^48^580^7^^^^1
 +47      ;;^UTILITY(U,$J,358.3,11918,1,0)
 +48      ;;=^358.31IA^3^2
 +49      ;;^UTILITY(U,$J,358.3,11918,1,2,0)
 +50      ;;=2^J7613
 +51      ;;^UTILITY(U,$J,358.3,11918,1,3,0)
 +52      ;;=3^ALBUTEROL,NON-COMPOUND,UNIT DOSE,1MG
 +53      ;;^UTILITY(U,$J,358.3,11919,0)
 +54      ;;=J2680^^48^580^41^^^^1
 +55      ;;^UTILITY(U,$J,358.3,11919,1,0)
 +56      ;;=^358.31IA^3^2
 +57      ;;^UTILITY(U,$J,358.3,11919,1,2,0)
 +58      ;;=2^J2680
 +59      ;;^UTILITY(U,$J,358.3,11919,1,3,0)
 +60      ;;=3^FLUPHENAZINE DECANOATE,UP TO 25MG
 +61      ;;^UTILITY(U,$J,358.3,11920,0)
 +62      ;;=J1580^^48^580^47^^^^1
 +63      ;;^UTILITY(U,$J,358.3,11920,1,0)
 +64      ;;=^358.31IA^3^2
 +65      ;;^UTILITY(U,$J,358.3,11920,1,2,0)
 +66      ;;=2^J1580
 +67      ;;^UTILITY(U,$J,358.3,11920,1,3,0)
 +68      ;;=3^GARAMYCIN,GENTAMICIN,UP TO 80MG
 +69      ;;^UTILITY(U,$J,358.3,11921,0)
 +70      ;;=J2350^^48^580^80^^^^1
 +71      ;;^UTILITY(U,$J,358.3,11921,1,0)
 +72      ;;=^358.31IA^3^2
 +73      ;;^UTILITY(U,$J,358.3,11921,1,2,0)
 +74      ;;=2^J2350
 +75      ;;^UTILITY(U,$J,358.3,11921,1,3,0)
 +76      ;;=3^OCRELIZUMAB 1MG
 +77      ;;^UTILITY(U,$J,358.3,11922,0)
 +78      ;;=J3590^^48^580^105^^^^1
 +79      ;;^UTILITY(U,$J,358.3,11922,1,0)
 +80      ;;=^358.31IA^3^2
 +81      ;;^UTILITY(U,$J,358.3,11922,1,2,0)
 +82      ;;=2^J3590
 +83      ;;^UTILITY(U,$J,358.3,11922,1,3,0)
 +84      ;;=3^UNCLASSIFIED BIOLOGICS
 +85      ;;^UTILITY(U,$J,358.3,11923,0)
 +86      ;;=J3490^^48^580^106^^^^1
 +87      ;;^UTILITY(U,$J,358.3,11923,1,0)
 +88      ;;=^358.31IA^3^2
 +89      ;;^UTILITY(U,$J,358.3,11923,1,2,0)
 +90      ;;=2^J3490
 +91      ;;^UTILITY(U,$J,358.3,11923,1,3,0)
 +92      ;;=3^UNCLASSIFIED DRUG
 +93      ;;^UTILITY(U,$J,358.3,11924,0)
 +94      ;;=J0135^^48^580^3^^^^1
 +95      ;;^UTILITY(U,$J,358.3,11924,1,0)
 +96      ;;=^358.31IA^3^2
 +97      ;;^UTILITY(U,$J,358.3,11924,1,2,0)
 +98      ;;=2^J0135
 +99      ;;^UTILITY(U,$J,358.3,11924,1,3,0)
 +100     ;;=3^ADALIMUMAB 20MG
 +101     ;;^UTILITY(U,$J,358.3,11925,0)
 +102     ;;=J1569^^48^580^45^^^^1
 +103     ;;^UTILITY(U,$J,358.3,11925,1,0)
 +104     ;;=^358.31IA^3^2
 +105     ;;^UTILITY(U,$J,358.3,11925,1,2,0)
 +106     ;;=2^J1569
 +107     ;;^UTILITY(U,$J,358.3,11925,1,3,0)
 +108     ;;=3^GAMMAGARD LIQUID 500MG
 +109     ;;^UTILITY(U,$J,358.3,11926,0)
 +110     ;;=J1566^^48^580^51^^^^1
 +111     ;;^UTILITY(U,$J,358.3,11926,1,0)
 +112     ;;=^358.31IA^3^2
 +113     ;;^UTILITY(U,$J,358.3,11926,1,2,0)
 +114     ;;=2^J1566
 +115     ;;^UTILITY(U,$J,358.3,11926,1,3,0)
 +116     ;;=3^IMMUNE GLOBULIN 500MG
 +117     ;;^UTILITY(U,$J,358.3,11927,0)
 +118     ;;=J2182^^48^580^69^^^^1
 +119     ;;^UTILITY(U,$J,358.3,11927,1,0)
 +120     ;;=^358.31IA^3^2